Philippines President Orders Prices Of Five ‘Essential Drugs' Cut In Half
This article was originally published in PharmAsia News
The Philippines president ordered a cap on the prices of five types of drugs deemed essential, with the effect of cutting the prices in half as of Aug. 15. The action had been recommended after drug makers failed to lower the prices of the five drugs on their own while agreeing to cut them on another 16 on the government's list. The industry also volunteered to cut prices of some drugs not on the list and said the order by President Gloria Macapagal Arroyo was not the best way to get essential drugs to The Philippines' poor. (Click here for more
You may also be interested in...
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.
In the age of coronavirus, human factors professionals are doing their best to find their way through the pandemic by putting unique twists on usability testing to see what works and what doesn’t in the new reality. That’s the topic of this week’s podcast.